Minimally invasive implantable neurostimulation system
US11957894B2 · kind B2 · utility
1Cited by
88References
24Claims
0Family size
Assignee
Inventors
- Anthony M. Chasensky
- Bernard Q. Li
- Brad C. Tischendorf
- Chris J. Paidosh
- Christian S. Nielsen
- Craig L. Schmidt
- David A. Dinsmoor
- Duane L. Bourget
- Eric H. Bonde
- Erik R. Scott
- Forrest C. M. Pape
- Gabriela C. Molnar
- Gordon O. Munns
- Joel A. Anderson
- John E. Kast
- Joseph J. Viavattine
- Markus W. Reiterer
- Michael J. Ebert
- Phillip C. Falkner
- Prabhakar A. Tamirisa
- Randy S. Roles
- Reginald D. Robinson
- Richard T. Stone
- Shawn C. Kelley
- Stephen J. Roddy
- Thomas P. Miltich
- Timothy J. Denison
- Todd V. Smith
- Xuan K. Wei
Key dates
| Filing date | Aug 25, 2020 |
| Grant date | Apr 16, 2024 |
| Priority date | — |
| Expiry date | Dec 13, 2041 |
Classification
- Technology area (CPC F)Mechanical Engineering; Lighting; Heating
- CPC primaryF04C2270/0421
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.